HARVARD BIOSCIENCE, INC. (HBIO) Operating cash flow 2016–2025
HARVARD BIOSCIENCE, INC. (HBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$6.7MFY2025 · since FY2016: $5.4M → $6.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.7M | +367.3% |
| FY2024 | $1.4M | -89.7% |
| FY2023 | $14.0M | +1117.7% |
| FY2022 | $1.2M | -8.7% |
| FY2021 | $1.3M | -86.5% |
| FY2020 | $9.3M | +16.0% |
| FY2019 | $8.0M | +179.0% |
| FY2018 | $2.9M | +172.8% |
| FY2017 | $1.1M | -80.4% |
| FY2016 | $5.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HBIO financial trends
HBIO RevenueHBIO Net incomeHBIO Net marginHBIO Gross profitHBIO Gross marginHBIO Operating incomeHBIO Operating marginHBIO Free cash flowHBIO Capital expendituresHBIO Return on equityHBIO Stock buybacksHBIO Dividends paidHBIO Total assetsHBIO Total liabilitiesHBIO Shareholders’ equityHBIO overview →